Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

0.1907 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,959
Open 0.1907
Bid (Size) 0.1800 (100)
Ask (Size) 0.1892 (5,200)
Prev. Close 0.1907
Today's Range 0.1907 - 0.1907
52wk Range 0.1151 - 2.710
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Which stocks are moving after the closing bell on Tuesday? ↗
After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Unusual volume stocks in Tuesday's session ↗
Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill

Performance

YTD
-92.3%
-92.3%
1 Month
-49.8%
-49.8%
3 Month
-70.6%
-70.6%
6 Month
-78.9%
-78.9%
1 Year
-91.4%
-91.4%

More News

Read More
News headline image
Monday's after hours session: top gainers and losers ↗
Via Chartmill
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
Via TheNewswire.com
GeoVax Addresses Identification of New Mpox Variant
Via TheNewswire.com
Topics Supply Chain
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board
Via TheNewswire.com
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
Via NewMediaWire
Topics Regulatory Compliance
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering
Via TheNewswire.com
Topics Regulatory Compliance
News headline image
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
Via NewMediaWire
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine
Via TheNewswire.com
News headline image
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA
Via NewMediaWire
News headline image
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
Via NewMediaWire
Topics Supply Chain
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026
Via TheNewswire.com
Topics Supply Chain
News headline image
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
Via NewMediaWire
Topics Intellectual Property
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design
Via TheNewswire.com
Topics Intellectual Property
News headline image
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
Via NewMediaWire
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients
Via TheNewswire.com
News headline image
GeoVax Addresses Identification of New Mpox Variant
Via NewMediaWire
Topics Supply Chain
News headline image
GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board
Via NewMediaWire
News headline image
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy
Via NewMediaWire
Topics Intellectual Property
GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy
Via TheNewswire.com
Topics Intellectual Property

Frequently Asked Questions

Is GeoVax Labs, Inc. - Common Stock publicly traded?
Yes, GeoVax Labs, Inc. - Common Stock is publicly traded.
What exchange does GeoVax Labs, Inc. - Common Stock trade on?
GeoVax Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeoVax Labs, Inc. - Common Stock?
The ticker symbol for GeoVax Labs, Inc. - Common Stock is GOVX on the Nasdaq Stock Market
What is the current price of GeoVax Labs, Inc. - Common Stock?
The current price of GeoVax Labs, Inc. - Common Stock is 0.1907
When was GeoVax Labs, Inc. - Common Stock last traded?
The last trade of GeoVax Labs, Inc. - Common Stock was at 12/23/25 04:00 PM ET
What is the market capitalization of GeoVax Labs, Inc. - Common Stock?
The market capitalization of GeoVax Labs, Inc. - Common Stock is 414.26K
How many shares of GeoVax Labs, Inc. - Common Stock are outstanding?
GeoVax Labs, Inc. - Common Stock has 414K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.